Congratulations to our faculty members who have recently received new or renewal grant funding!
David Ford, Ph.D., received a new R01 grant from the National Institute of Environmental Health Sciences at the NIH entitled “Lipid and metabolic mechanisms responsible for phosgene and phosphorus trichloride exposure toxicity.”
The project will study the mechanisms responsible of toxicity of phosgene and phosphorous trichloride, which are common public health threats resulting from industrial accidents or chemical warfare. Researchers hope to find therapeutic targets to use as countermeasures against these harmful chemicals.
Yie-Hwa Chang, Ph.D., will be Co-PI on a new U01 grant from the National Cancer Institute at the NIH entitled “Innovative rapid enabling, affordable, point-of-care HPV self-testing strategy (I-REACH).”
The project hopes to use innovative strategies to create a woman-centered HPV self-test kit for use in Nigeria, where access to Pap smears and conventional HPV testing is limited. The researchers will use crowdsourcing and other tools to empower women to take control of their healthcare needs and give them the tools needed to prevent cervical cancer.
Reza Dastvan, Ph.D., has received a second new R01 grant from the National Institute of General Medical Sciences at the NIH entitled “Structural dynamics of sphigosine-1-phosphate transporters as key therapeutic targets for immune system modulation and cancer.”
Reza also received an supplement $30,000 administrative supplement to his R01 grant from the National Cancer Institute entitled “Novel molecular mechanism for extracelllular release of proteins implicated in metastatic cancer.”
